A needle and the damage done: Fatal forty DDI: Buprenorphine, ritonavir, CYP3A4

James Hilliard; Kirk Lalwani

doi:10.1007/978-1-4614-7495-1_50

A needle and the damage done: Fatal forty DDI: Buprenorphine, ritonavir, CYP3A4

James Hilliard, Kirk Lalwani

Anesthesiology and Perioperative Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This case discusses a pharmacokinetic drug interaction between buprenorphine, ritonavir, and atazanavir. Buprenorphine is a cytochrome P450 3A4 substrate. Ritonavir and atazanavir are both potent 3A4 inhibitors.

Original language	English (US)
Title of host publication	A Case Approach to Perioperative Drug-Drug Interactions
Publisher	Springer New York
Pages	245-247
Number of pages	3
ISBN (Electronic)	9781461474951
ISBN (Print)	9781461474944
DOIs	https://doi.org/10.1007/978-1-4614-7495-1_50
State	Published - Sep 15 2015

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-4614-7495-1_50

Cite this

@inbook{90c988ae363443c1893d247bbc2a0090,

title = "A needle and the damage done: Fatal forty DDI: Buprenorphine, ritonavir, CYP3A4",

abstract = "This case discusses a pharmacokinetic drug interaction between buprenorphine, ritonavir, and atazanavir. Buprenorphine is a cytochrome P450 3A4 substrate. Ritonavir and atazanavir are both potent 3A4 inhibitors.",

author = "James Hilliard and Kirk Lalwani",

year = "2015",

month = sep,

day = "15",

doi = "10.1007/978-1-4614-7495-1_50",

language = "English (US)",

isbn = "9781461474944",

pages = "245--247",

booktitle = "A Case Approach to Perioperative Drug-Drug Interactions",

publisher = "Springer New York",

}

TY - CHAP

T1 - A needle and the damage done

T2 - Fatal forty DDI: Buprenorphine, ritonavir, CYP3A4

AU - Hilliard, James

AU - Lalwani, Kirk

PY - 2015/9/15

Y1 - 2015/9/15

N2 - This case discusses a pharmacokinetic drug interaction between buprenorphine, ritonavir, and atazanavir. Buprenorphine is a cytochrome P450 3A4 substrate. Ritonavir and atazanavir are both potent 3A4 inhibitors.

AB - This case discusses a pharmacokinetic drug interaction between buprenorphine, ritonavir, and atazanavir. Buprenorphine is a cytochrome P450 3A4 substrate. Ritonavir and atazanavir are both potent 3A4 inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=84955355015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955355015&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-7495-1_50

DO - 10.1007/978-1-4614-7495-1_50

M3 - Chapter

AN - SCOPUS:84955355015

SN - 9781461474944

SP - 245

EP - 247

BT - A Case Approach to Perioperative Drug-Drug Interactions

PB - Springer New York

ER -

A needle and the damage done: Fatal forty DDI: Buprenorphine, ritonavir, CYP3A4

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this